Hydrogen-bonded cocrystals of the drug metformin: from molecular interactions analysis to supramolecular synthesis and characterization of Met-bis(DCA), a pharmaceutical cocrystal with enhanced anti-leukemic activity by Gilli, Paola & Cvetkovski, Aleksandar
30th European Crystallographic Meeting, 28th August - 1st September 2016, Congress Center Basel, Switzerland
s114                                                                                         Acta Cryst. (2016). A72, s114
MS30-O4 Supramolecular reactivity in the
solid state: Step-wise assembly of ternary
cocrystals through hydrogen and halogen
bonding
Filip Topić1, Dominik Cinčić2, Vladimir Stilinović2, Kari
Rissanen1
1. Department of Chemistry, Nanoscience Center, University of
Jyväskylä, Finland
2. Department of Chemistry, Faculty of Science, University of
Zagreb, Croatia
email: filip.f.topic@jyu.fi
In the field of crystal engineering, cocrystals have been
among the most pursued topics in the last two decades.[1]
Devising rational strategies for systematically assembling
them has been one of the greatest challenges, even more
so for cocrystals consisting of more than two
components. Whereas both mechanochemical assembly
and disassembly of the binary cocrystals have been
studied [2,3], the supramolecular reactivity of ternary
cocrystals is still almost unexplored [4].
Given our interest in the orthogonality of hydrogen and
halogen bonding in the context of supramolecular
chemistry, we focused our interest on the combination of
thioureas, phosphine oxides and various halogen bond
donors. These types of molecules are known to form
binary cocrystals through hydrogen (thiourea and
phosphine oxide) or halogen bonds (thioureas or
phosphine oxides with different halogen bond donors),
and we hypothesized that the combination of all three
might yield ternary cocrystals.
Our initial studies revealed successful formation of a
number of ternary cocrystals, primarily sustained by
N−H···O hydrogen bonds between thioureas and
phosphine oxides and C−I···S halogen bonds between
thioureas and halogen bond donors. Next, reactivity
studies were performed in the following way: First, for a
given set of three components A, B, C, each two were
ground together to probe for the formation of binary
cocrystals AB, BC and AC. Subsequently, each of the
resulting mixtures or cocrystals was ground with the third
component from the set to probe for the formation of
ternary solid ABC. These experiments revealed a
spectrum of possible outcomes, from component sets
where all of AB, BC, AC and ABC were successfully
formed, to such cases where only binary cocrystal AB
was detected, with all other combinations only yielding
various mixtures. Structures of the obtained binary and
ternary cocrystals, as well as the results of the
mechanochemical experiments, will be discussed.
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N,N-dimethylbiguanide, metformin (Met) in the medical
literature, is a widely used active pharmaceutical
ingredient (API) of the biguanide class. Besides being the
drug of first choice for oral therapy of type 2 diabetes, its
anticancer activity is the subject of active research. Met
can exist in three resonance-stabilized forms, i.e. as
neutral molecule (Met), monoprotonated (MetH+) or
diprotonated (MetH22+) cation, with dissociationconstants in water typical of biguanides: pKa1~12.40;pKa2=2.96.
We have investigated the crystal chemistry of Met in
series of pharmaceutical cocrystals (PCC) prepared using
various acids as coformers (CF), with particular focus on
Generally Recognized as Safe (GRAS) compounds,
nutraceuticals and APIs. By cocrystallization under
different conditions we obtained 33 PCCs of a quality
suitable for structural determination, 27 containing MetH+
and 6 MetH22+. The delocalized biguanide fragment isnever found to be planar and the  hydrogen bond
(H-bond) is the dominating molecular interaction. Crystal
packing analysis reveals that Met and CF molecules are
linked by extended H-bond networks with a number of
conserved patterns (dimers, rings, ribbons, sheets, etc).
The H-bond strength is increasing with decreasing ΔpKaaccording to the PA/pKa equalization principle. Allcomplexes formed by Met with acidic compounds are
salts, as predictable from the thermodynamic acid-base
constants. As a consequence of the high value of pKa1(12.40),  neutral Met is easily protonated at the iminic
nitrogen even by weak acids, giving rise to 1:1 ionic
adducts consisting of monoprotonated MetH+ and one
anion, but since pKa2 is much smaller (2.96), only strongacids succeed in protonating the secondary amino
nitrogen, forming 1:2 ionic adducts consisting of
diprotonated MetH22+ and two anions.
As successful application, we report the  crystal
engineering, supramolecular synthesis, crystal structure
determination and in vitro biological activity testing of
two new PCCs of Met with the antileukemic drug
dichloroacetic acid (DCA, pKa=0.9) in 1:1 (1,MetH+∙DCA-) and 1:2 (2, MetH22+∙2DCA-) ratio,respectively. The activity of 1 resembles closely the 1:1
physical mixture of NaDCA and Met.HCl, while 2
displays a significantly higher activity and induces a
synergistic apoptotic cell death on primary cells of human
patients. To our best knowledge, 2 is the first PCC
displaying a synergistic enhancement of the anticancer
activity of two APIs.
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